首页 | 本学科首页   官方微博 | 高级检索  
检索        

地佐辛与吗啡用于P.P.H术后镇痛的比较
引用本文:李练喜,董师武.地佐辛与吗啡用于P.P.H术后镇痛的比较[J].现代保健,2012(15):35-36.
作者姓名:李练喜  董师武
作者单位:广东省鹤山市人民医院,广东鹤山529700
摘    要:目的:观察地佐辛复合布比卡因与吗啡复合罗哌卡因用于P.P.H( 痔上黏膜环切吻合术) 术后硬膜外镇痛的镇痛效果与不良反应的比较.方法:将100 例P.P.H 手术患者随机分为两组,硬膜外输后镇痛泵地佐辛组( 治疗组):地佐辛0.5 mg/kg+ 罗哌卡因+ 生理盐水至100 ml.吗啡组( 对照组):吗啡1 μg/kg+ 罗哌卡因+ 生理盐水至100 ml 统计48 h 患者视觉模拟评分(VAS) 及不良反应发生率.结果:两组观察VAS 评分无统计学意义(P〉0.05),地佐辛组( 治疗组) 术后镇痛不良反应发生率明显低于吗啡组( 对照组),差异有统计学意义(P〈0.05).结论:地佐辛复合罗哌卡因用于P.P.H 术后硬膜外术后镇痛,镇痛效果确切,而且较吗啡复合罗哌卡因不良反应少,所以更适合.

关 键 词:地佐辛  吗啡  P.P.H  术后硬膜外镇痛

Michael Essien to Assist with Morphine for P.P.H Postoperative Analgesia Comparison
Authors:LI Lian-xi  DONG Shi-wu
Institution:(People' s Hospital of Heshan, Jiangmen 529100, China)
Abstract:Objective: To observe the analgesic effect of dezocine combined with levobupivacaine used for epidural analgesia after the operation of P.P.H(procedure for prolapse and hemorrhoids) and the compassion among untoward effects. Methods: 100 patients who would accept P.P.H operation were randomly divided into two groups. Epidural post-operation analgesia pump dezocine group(Group A): 0.5 mg/kg dezocine + ropivacaine + normal saline, 100 ml in all. Morphine group (Group B): 1μg/kg Morphine + Ropivacaine + normal saline, 100 ml in all. Calculate patients' visual analogue scale (VAS) and the incidence of untoward effects within 48 hours. Results: After observing VAS grades of two groups, there was no statistical significance(P〉0.05), while the incidence of untoward effects post-operation analgesia of dezocine group was obviously lower than that of Morphine group, so there was statistical significance(P〈0.05). Conclusion: The effect of Dezocine combined with levobupivacaine used for epidural analgesia after the operation of P.P.H is obvious. And its untoward effects are less than the morphine combined with ropivacaine, so it will be more appropriate for the operation of P.P.H.
Keywords:Dezocine  Morphine  P  P  H  P  C  E  A
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号